Pluri (PLUR) Cash from Operations Growth (3y) (2013 - 2025)
Pluri (PLUR) Cash from Operations Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
37.40% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
16.64% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Pluri |
21.39 Mn |
21.87 Mn |
86,000.00 |
6.07% |
| Date | Value |
|---|
| Dec 31, 2025 |
6.07% |
| Sep 30, 2025 |
10.65% |
| Jun 30, 2025 |
14.78% |
| Mar 31, 2025 |
22.99% |
| Dec 31, 2024 |
22.29% |
| Sep 30, 2024 |
22.67% |
| Jun 30, 2024 |
23.40% |
| Mar 31, 2024 |
16.92% |
| Dec 31, 2023 |
22.51% |
| Sep 30, 2023 |
1.57% |
| Jun 30, 2023 |
22.90% |
| Mar 31, 2023 |
2.28% |
| Dec 31, 2022 |
0.11% |
| Sep 30, 2022 |
-1.67% |
| Jun 30, 2022 |
-8.09% |
| Mar 31, 2022 |
-16.19% |
| Dec 31, 2021 |
-6.08% |
| Sep 30, 2021 |
-1.08% |
| Jun 30, 2021 |
-18.37% |
| Mar 31, 2021 |
-9.54% |
